| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $51.3M | +63.0% |
| R&D Expense | $83.3M | +9.3% |
| SG&A Expense | $100.4M | +4.9% |
| Operating Income | -$136.2M | +4.4% |
| Pre-tax Income | -$145.9M | +1.1% |
| Income Tax | $1.7M | +83.8% |
| Net Income | -$147.6M | +0.5% |
| EPS (Basic) | -$3.38 | +4.5% |
| EPS (Diluted) | -$3.38 | +4.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.6M | -57.2% |
| Short-term Investments | $50.5M | — |
| Accounts Receivable | $11.1M | +95.0% |
| Inventory | $16.2M | +366.1% |
| Current Assets | $179.5M | -26.3% |
| Total Assets | $188.0M | -26.0% |
| Current Liabilities | $35.6M | +28.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$128.6M | +2.6% |
| Capital Expenditures | $506K | — |
| Investing Cash Flow | -$50.5M | — |
| Financing Cash Flow | $52.5M | -64.0% |
| Free Cash Flow | -$129.1M | +2.3% |
| Long-term Debt |
| $75.0M |
| +0.0% |
| Total Liabilities | $119.2M | +7.8% |
| Stockholders' Equity | $68.7M | -52.1% |